Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat

Molecular and Cellular Biochemistry

Volumn 206, Issue 1-2, 2000, Pages 151-157

  Broderick, Tom L ^a   Driedzic, William ^b   Paulson, Dennis J ^c  

^a MIDWESTERN UNIVERSITY   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c MIDWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac function; Diabetes; Ischemia; Oxidation; Propionyl L carnitine

Indexed keywords

GLUCOSE; PALMITIC ACID; PROPIONYLCARNITINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIABETES MELLITUS; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0034066555     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007022114594     Document Type: Article

References (48)

1. Fein FS: Diabetic cardiomyopathy. Diabetes Care 13:(suppl 4) 1169-1179, 1990
2. Kannel WB, Hjortland M, Castelli WP: The role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 34: 29-34, 1974
3. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: The Framingham study. Circulation 59: 8-13, 1976
4. Regan TJ: Congestive heart failure in the diabetic. Ann Rev Med 34: 161-168, 1983
5. Lopaschuk GD: Abnormal mechanical function in diabetes: Relationship to altered myocardial carbohydrate/lipid metabolism. Cor Art Dis 7: 116-123, 1996
6. Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet 343: 155-158, 1994
7. Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169-179, 1995
8. Garvey WT, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transporter systems in rats: Implications for diabetic cardiomyopathy. Am J Physiol 264: H837-H844, 1993
9. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, Sacca L, Toffolo G, Cobelli C, Trevisan R: Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 258: H606-H618, 1990
10. Pierce GN, Dhalla NS: Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1: 48-54, 1984
11. Wall SR, Lopaschuk GD: Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochem Biophys Acta 1006: 97-1003, 1989
12. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of the heart. Ann Rev Physiol 36: 413-459, 1974
13. Kerbey AL, Vary TC, Randle PJ: Molecular mechanisms regulating glucose oxidation. Basic Res Cardiol 80:(suppl 2) 93-96, 1995
14. Paulson DJ, Crass MF: Endogenous triacylglycerol metabolism in diabetic heart. Am J Physiol 242: H1084-H1094, 1982
15. Chatham JC, Forder JR: Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol 273: H52-H58, 1997
16. Bunger R, Mallet RT, Hartman DA: Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Eur J Biochem 180: 231-233, 1989
17. Liedtke AJ, DeMaison L, Nellis S: Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 255: H169-H176, 1988
18. Lopaschuk GD: Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. Am J Cardiol 80: 11A-16A, 1997
19. Broderick, TL, Quinney HA, Lopaschuk GD: L-carnitine increases glucose metabolism and mechanical function following ischemia in diabetic rat heart. Cardiovasc Res 29: 373-378, 1995
20. McVeigh JJ, Lopaschuk GD: Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259: H1070-H1085, 1990
21. Nichol TA, Lopaschuk GD, McNeill JH. The effects of free fatty acids and dichloroacetate on the isolated working diabetic rat heart. Am J Physiol 261: H1053-H1059, 1991
22. Arsenian MA: Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 40: 265-286, 1997
23. Bartels GL, Remme WJ, Pillay M, Schonfeld DHW, Cox PH, Kruijssen M, Knuf NMJ: Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 20: 157-164, 1992
24. El Alaoui-Talibi Z, Guendouz A, Moravec M, Moravec J: Control of oxidative metabolism in volume-overloaded rat hearts: Effect of propionyl-L-carnitine. Am J Physiol 272: H1615-H1624, 1997
25. Ferrari R, DeGuili F: The propionyl-L-carnitine hypothesis: An alternative approach to treating heart failure. J Card Fail 3: 217-224, 1997
26. Paulson DJ, Shug AL, Zhao J: Protection of the ischemic diabetic heart by L-propionylcarnitine therapy. Mol Cell Biochem 116: 131-137, 1992
27. Schonekess B, Allard MF, Lopaschuk GD: Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 77: 726-734, 1995
28. Broderick TL, Haloftis G, Paulson DJ: L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. J Mol Cell Cardiol 28: 331-340, 1996
29. Saddik M, Lopaschuk GD: Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 72: 1110-1119, 1994
30. Terada R, Matsubara T, Koh N, Nakamura J, Hotta N: Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats. Eur J Pharmacol 357: 185-191, 1998
31. Packer L, Valenza M, Serbinova E, Starke-Reed P, Frost K, Kagan V: Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys 288: 522-527, 1991
32. Pengfei WU, Sato J, Zhao Y, Jaskiewics J, Popov KM, Harris RA: Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J 329: 197-202, 1998
33. Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 34: 113-120, 1997
34. Paulson DJ: The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34: 104-112, 1997
35. Broderick TL, Barr RL, Quinney AH, Lopaschuk GD: Acute insulin withdrawal from diabetic BB rats decreases myocardial glycolysis during low-flow ischemia. Metabolite 41: 332-338, 1992
36. Hekimian G, Feuvray D: Reduction of ischemia-induced acylcarnitine accumulation by TGDA and its influence on lactate dehydrogenase release in diabetic rat hearts. Diabetes 35: 906-910, 1986
37. Paulson DJ, Kopp J, Peace DJ, Tow JP: Improved postischemic recovery of cardiac pump function in exercised trained diabetic rats. J Appl Physiol 65: 187-193, 1988
38. + exchange during ischemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res 24: 873-878, 1990
39. 2+ metabolism. Circ Res 62: 931-940, 1988
40. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD: Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 87: 972-981, 1993
41. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD: Ranozaline stimulates glucose oxidation in the normoxic, ischemic and reperfused ischemic hearts. Circulation 93: 135-142, 1996
42. Gamble J, Lopaschuk GD: Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochem Biophys Acta 1225: 191-199, 1994
43. Tassani V, Cattapan F, Magnanimi L, Peschechera A: Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Biochem Biophys Res Commun 198: 949-952, 1994
44. Russell RR, Mommessin JI, Taegtmeyer H: Propionyl-L-carnitine-mediated improvements in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 268: H441-H447, 1995
45. De Lisa F, Menabo R, Siliprandi N: L-propionyl-carnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem 88: 169-173, 1989
46. Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL: Quantification of the effect of L-carnitine on the levels of acid-soluble short-chain acyl CoA in rat heart and liver mitochondria. J Biol Chem 263: 1511-1516, 1988
47. Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267: 3758-3763, 1992
48. Rodrigues B, Xiang H, McNeill JH: Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358-1364, 1988